Balaxi Pharmaceuticals Limited, a active public limited company, was established on 28 September 1942 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: L25191TG1942PLC121598. Registered under ROC Roc Hyderabad. it is listed on NSE: BALAXI. It has an authorized capital of ₹40.00 Cr and a paid-up capital of ₹11.04 Cr.
Formerly known as Balaxi Ventures Limited, Anandam Rubber Company Limited. It upholds a compliant status. In 2024, it reported revenue of ₹72.59 Cr and a net worth of ₹117.77 Cr. Employing 49 professional, Its leadership includes Gandhi Gamji (Director), Mangina Rao Srinivas (Director), Kunal Mahendra Bhakta (Director). Past directors included Gandhi Gamji, Bobby Jose Arakunnel, Mangina Rao Srinivas. It holds ₹35.00 Cr open charges and ₹34.29 Cr settled loans. Its latest AGM occurred on 25 August 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.409,H.No. 8-2-293, Maps Towers 3Rd Floor, Phase-Iii, Road No.81,Jubilee, Hills, Hyderabad, Telangana, 500096.
L25191TG1942PLC121598
121598
28 September 1942
₹40.00 Cr
₹11.04 Cr
Roc Hyderabad
Listed (NSE: BALAXI)
Active
Explore comprehensive insights into Balaxi Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gandhi Gamji | Director | 04 May 2017 | Current |
| Mangina Rao Srinivas | Director | 15 Sep 2020 | Current |
| Kunal Mahendra Bhakta | Director | 04 May 2017 | Current |
| Akshita Surana | Director | 05 Sep 2024 | Current |
| Ashish Maheshwari | Managing Director | 04 May 2017 | Current |
| Maheshwari Minoshi | Director | 04 May 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 08 Aug 2017 | Past |
| Pramod Abcsdd | Director | 20 Dec 2014 | Past |
| Pramod Abcsdd | Additional Director | 25 Aug 2021 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Director | 09 Feb 2011 | Past |
| Pramod Abcsdd | Director | 04 May 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Balaxi Pharmaceuticals Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 36.73% decrease. The company also saw a substantial fall in profitability, with a 77.5% decrease in profit. The company's net worth Soared by an impressive increase of 43.96%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Balaxi Pharmaceuticals had a promoter holding of 66.86% and a public holding of 33.13%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹350,000,000.00
₹342,885,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Sep 2024 | Yes Bank Limited | ₹35.00 Cr | Open |
| 26 Jul 2022 | Others | ₹31.00 Cr | Satisfied |
| 29 Jun 2021 | Yes Bank Limited | ₹1.00 Cr | Satisfied |
| 23 Jun 2020 | Others | ₹2.10 M | Satisfied |
| 22 Apr 2015 | Hedge Finance Limited | ₹2.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Balaxi Pharmaceuticals has a workforce of 49 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Balaxi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Balaxi Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Balaxi Pharmaceuticals Limited last Annual general meeting of members was held on 25 Aug 2025 as per latest MCA records. was documented.
Balaxi Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.
The activity Mohith Kumar Khandelwal was appointed as a Company Secretary was appointed as a Company Secretary on 21 Nov 2024 & has been associated with this company since 1 year 3 days . was completed.
The activity A charge registered on 26 Jul 2022 via Charge ID 100634052 with Others was fully satisfied on 13 Nov 2024. was completed.
The activity A charge with Yes Bank Limited amounted to Rs. 35.00 Cr with Charge ID 100983181 was registered on 16 Sep 2024. was completed.
A charge registered on 29 Jun 2021 via Charge ID 100459808 with Yes Bank Limited was fully satisfied on 05 Sep 2024. was recorded as a recent event.
The CIN of Balaxi Pharmaceuticals Limited is L25191TG1942PLC121598.
Balaxi Pharmaceuticals Limited is headquartered at Plot No.409,H.No. 8-2-293, Maps Towers 3Rd Floor, Phase-Iii, Road No.81,Jubilee, Hills, Hyderabad, Telangana, 500096.
Balaxi Pharmaceuticals Limited was incorporated on 28 September 1942.
The current directors of Balaxi Pharmaceuticals Limited are
The primary industry of Balaxi Pharmaceuticals Limited is Trade.
Balaxi Pharmaceuticals Limited is listed. It is listed on NSE: BALAXI.
The authorized capital of Balaxi Pharmaceuticals Limited is ₹40.00 Cr, and the paid-up capital is ₹11.04 Cr.
The compliance status of Balaxi Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX